Expression of biotransformation enzymes in human fetal olfactory mucosa: Potential roles in developmental toxicity

Toxicology and Applied Pharmacology

Volumn 165, Issue 2, 2000, Pages 158-162

  Gu, Jun ^a   Su, Ting ^a,b   Chen, Ying ^a,c   Zhang, Qing Yu ^a   Ding, Xinxin ^a,b  

^a WADSWORTH CENTER   (United States)

^b STATE UNIVERSITY OF NEW YORK   (United States)

^c SHANDONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450; EPOXIDE HYDROLASE; OXIDOREDUCTASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE FERRIHEMOPROTEIN REDUCTASE;

ARTICLE; BIOTRANSFORMATION; ENZYME ACTIVATION; FETUS; HUMAN; HUMAN TISSUE; MICROSOME; OLFACTORY EPITHELIUM; PERINATAL DEVELOPMENT; PROTEIN EXPRESSION; TOXICITY;

EID: 0034212519     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.2000.8923     Document Type: Article

References (31)

1. Belinsky S. A., Walker V. E., Maronpot R. R., Swenberg J. A., Anderson M. W. Molecular dosimetry of DNA adduct formation and cell toxicity in rat nasal mucosa following exposure to tobacco-specific nitrosamine 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone and their relationship to induction of neoplasia. Cancer Res. 47:1987;6058-6065.
2. Bonnefoi M., Monticello T. M., Morgan K. T. Toxic and neoplastic responses in the nasal passages: future research needs. Exp. Lung Res. 17:1991;853-868.
3. Brittebo E. B. Metabolism of xenobiotics in the nasal olfactory mucosa: Implications for local toxicity. Pharmacol. Toxicol. 72:1993;50-52.
4. Dahl A. R., Hadley W. M. Nasal cavity enzymes involved in xenobiotic metabolism: Effects on the toxicity of inhalants. CRC Crit. Rev. Toxicol. 21:1991;345-372.
5. Deamer N. J., O'Callaghan J. P., Genter M. B. Olfactory toxicity resulting from dermal application of 2,6-dichlorobenzonitrile (dichlobenil) in the C57Bl mouse. Neurotoxicol. 15:1994;287-294.
6. Ding X., Coon M. J. Immunochemical characterization of multiple forms of cytochrome P-450 in rabbit nasal microsomes and evidence for tissue-specific expression of P450s NMa and NMb. Mol. Pharmacol. 37:1990;489-496.
7. Ding X., Coon M. J. Olfactory cytochrome P450. Handbook Expt. Pharmacol. 105:1993;351-361.
8. Ding X., Peng H.-M., Coon M. J. Cytochromes P450 NMa, NMb (2G1), and LM4 (1A2) are differentially expressed during development in rabbit olfactory mucosa and liver. Mol. Pharmacol. 42:1992;1027-1032.
9. Fernandez-Salguero P., Gonzalez F. J. The CYP2A gene subfamily: Species differences, regulation, catalytic activities and role in chemical carcinogenesis. Pharmacogenetics. 5:1995;S123-S128.
10. Genter M. B., Llorens J., O'Callaghan J. P., Peele D. B., Morgan K. T., Crofton K. M. Olfactory toxicity of β,β′-iminodipropionitrile in the rat. J. Pharmacol. Exp. Ther. 263:1992;1432-1439.
11. Gervasi P. G., Longo V., Naldi F., Panattoni G., Ursino F. Xenobiotic-metabolizing enzymes in human respiratory nasal mucosa. Biochem.Pharmacol. 41:1991;177-184.
12. Getchell M. L., Chen Y., Ding X., Sparks D. L., Getchell T. V. Immunohistochemical localization of a cytochrome P450 isozyme in human nasal mucosa: age-related trends. Otol. Rhinol. Laryngol. 102:1993;368-374.
13. Gu J., Walker V. E., Lipinskas T. W., Walker D. M., Ding X. Intraperitoneal administration of coumarin causes tissue-selective depletion of cytochromes P450 And cytotoxicity in the olfactory mucosa. Toxicol. Appl. Pharmacol. 146:1997;134-143.
14. Gu J., Zhang Q. Y., Genter M. B., Lipinskas T. W., Negishi M., Nebert D. W., Ding X. Purification and characterization of heterologously expressed mouse CYP2A5 and CYP2G1 - role in metabolic activation of acetaminophen and 2,6-dichlorobenzonitrile in mouse olfactory mucosal microsomes. J. Pharmacol. Exp. Ther. 285:1998;1287-1295.
15. Hakkola J., Pelkonen O., Pasanen M., Raunio H. Xenobiotic-metabolizing cytochrome P450 enzymes in the human feto-placental unit - role in intrauterine toxicity. CRC Crit. Rev. Toxicol. 28:1998;35-72.
16. Koskela S., Hakkola J., Hukkanen J., Pelkonen O., Sorri M., Saranen A., Anttila S., Fernandez-Salguero P., Gonzalez F., Raunio H. Expression of CYP2A genes in human liver and extrahepatic tissues. Biochem. Pharmacol. 57:1999;1407-1413.
17. Lackmann G. M., Salzberger U., Tollner U., Chen M., Carmella S. G., Hecht S. S. Metabolites of a tobacco-specific carcinogen in urine from newborns. J. Natl. Cancer Inst. 91:1999;459-465.
18. Liu C., Zhuo X., Gonzalez F. J., Ding X. Baculovirus-mediated expression and characterization of rat CYP2A3 and human CYP2A6: Role in metabolic activation of nasal toxicants. Mol. Pharmacol. 50:1996;781-788.
19. Longo V., Pacifici G. M., Panattoni G., Ursino F., Gervasi P. G. Metabolism of diethylnitrosamine by microsomes of human respiratory nasal mucosa and liver. Biochem. Pharmacol. 38:1989;1867-1869.
20. Maenpaa J., Rane A., Raunio H., Honkakoski P., Pelkonen O. Cytochrome P450 isoforms in human fetal tissues related to phenobarbital-inducible forms in the mouse. Biochem. Pharmacol. 45:1993;899-907.
21. Margalit T., Lancet D. Expression of olfactory receptor and transduction genes during rat development. Dev. Brain Res. 73:1993;7-16.
22. Nelson D. R., Koymans L., Kamataki T., Stegeman J. J., Feyereisen R., Waxman D. J., Waterman M. R., Gotoh O., Coon M. J., Estabrook R. W., Gunsalus I. C., Nebert D. W. P450 superfamily: Update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics. 6:1996;1-42.
23. Schaal B., Marlier L., Soussignan R. Olfactory function in the human fetus: Evidence from selective neonatal responsiveness to the odor of amniotic fluid. Behav. Neurosci. 112:1998;1438-1449.
24. Su, T, Bao, Z, Zhang, Q. Y, Smith, T. J, Hong, J. Y, and, Ding, X. [unpublished results].
25. Su T., Sheng J. J., Thomas L. W., Ding X. Expression of CYP2A genes in rodent and human nasal mucosa. Drug Metab. Dispos. 24:1996;884-890.
26. Thornton-Manning J. R., Nikula K. J., Hotchkiss J. A., Avila K. J., Rohrbacher K. D., Ding X., Dahl A. R. Nasal cytochrome P450 2A: Identification, regional localization, and metabolic activity toward hexamethylphosphoramide, a known nasal carcinogen. Toxicol. Appl. Pharmacol. 142:1997;22-30.
27. Wu S., Moomaw C. R., Tomer K. B., Falck J. R., Zeldin D. C. Molecular cloning and expression of CYP2J2, a human cytochrome P450 arachidonic acid epoxygenase highly expressed in heart. J. Biol. Chem. 271:1996;3460-3468.
28. Yamano S., Nhamburo P. T., Aoyama T., Meyer U. A., Inaba T., Kalow W., Gelboin H. V., McBride O. W., Gonzalez F. J. cDNA cloning and sequence and cDNA-directed expression of human P450 IIB1: Identification of a normal and two variant cDNAs derived from the CYP2B locus on chromosome 19 and differential expression of the IIB mRNAs in human liver. Biochemistry. 28:1989;7340-7348.
29. Yamano S., Tatsuno J., Gonzalez F. J. The CYP2A3 gene product catalyzes coumarin 7-hydroxylation in human liver microsomes. Biochemistry. 29:1990;1322-1329.
30. Zhang Q. Y., Raner G., Ding X., Dunbar D., Coon M. J., Kaminsky L. S. Characterization of the cytochrome P450 CYP2J4-expression in rat small intestine and role in retinoic acid biotransformation from retinal. Arch. Biochem. Biophys. 353:1998;257-264.
31. Zhuo X. L., Gu J., Zhang Q. Y., Spink D. C., Kaminsky L. S., Ding X. Biotransformation of coumarin by rodent and human cytochromes P-450: Metabolic basis of tissue-selective toxicity in olfactory mucosa of rats and mice. J. Pharmacol. Exp. Ther. 288:1999;463-471.